tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
DMAC is currently covered by 3 analysts with an average price target of $15.2. This is a potential upside of $12.63 (491.44%) from yesterday's end of day stock price of $2.57.
DiaMedica Therapeutics's activity chart (see below) currently has 10 price targets and 15 ratings on display. The stock rating distribution of DMAC is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 3.33% with an average time for these price targets to be met of 120 days.
Highest price target for DMAC is $8, Lowest price target is $7, average price target is $15.2.
Most recent stock forecast was given by ALEXANDER NOWAK from CRAIG HALLUM on 24-Apr-2024. First documented stock forecast 03-Jan-2019.
Currently out of the existing stock ratings of DMAC, 2 are a HOLD (33.33%), 4 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$5.55 (226.53%)
11
2 days ago
1/5 (20%)
$5.55 (226.53%)
720
Buy
7
$4.55 (185.71%)
10 months 4 days ago
0/2 (0%)
$2.95 (72.84%)
Hold
1 years 9 months 19 days ago
0/2 (0%)
$17.96 (178.88%)
Buy
11
$8.42 (326.36%)
14
2 years 9 months 27 days ago
0/2 (0%)
$6.82 (124.75%)
Buy
38
2 years 9 months 28 days ago
0/1 (0%)
$27.58 (264.68%)
What is DMAC (DiaMedica Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DMAC (DiaMedica Therapeutics) with a proven track record?
Which analyst has the current lower performing score on DMAC (DiaMedica Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DMAC (DiaMedica Therapeutics)?
Which analyst is the currently most bullish on DMAC (DiaMedica Therapeutics)?
Which analyst is the currently most reserved on DMAC (DiaMedica Therapeutics)?
